23rd October 2020
MHRA post-transition period information from Pure Drug Safety
23rd October 2020

MHRA and EMA latest guidance on Brexit

As at 23 October 2020, the situation regarding a Deal or No Deal Brexit is extremely fluid. As such, rather than bombard you with our guesses […]
Do you like it?
Read more
3rd September 2020
MHRA post-transition period information from Pure Drug Safety
3rd September 2020

MHRA post-transition period information

On Monday 1 September 2020, the MHRA released an update to the guidance on pharmacovigilance post-transitional period and I am sure we all heard the emails […]
Do you like it?
Read more
12th February 2020
What happens after Brexit for Pharmacovigilance and Regulatory?
12th February 2020

What happens after Brexit for Pharmacovigilance and Regulatory?

Do you like it?
Read more
7th February 2020
Pharmacovigilance (QPPV) provision post-Brexit
7th February 2020

Pharmacovigilance (QPPV) provision post-Brexit

There has been and still is a huge amount of confusion regarding the requirements for establishing a UK QPPV following the UK’s exit from Europe on […]
Do you like it?
Read more
15th January 2020
15th January 2020

Is your pharmaceutical company Brexit ready?

Pure Drug Safety is ready to help you with your post Brexit pharmacovigilance and regulatory requirements – deal or no deal. Just call us now for […]
Do you like it?
Read more